Table 1.
List of COVID-19 vaccines authorized for emergency or full use as of November 8, 2021. Manufacturer information, date of first authorization, number of doses, timing of doses, and corresponding VIOLIN and VO entries are also listed.
| Vaccine Name | Manufacturer | Date of First Authorization | Number of Doses | Timing of Doses | VIOLIN ID | VO ID |
|---|---|---|---|---|---|---|
| DNA Vaccines | ||||||
| ZyCoV-D | Zydus Cadila | August 20, 2021 | 3 | Day 0 + 28 + 56 | 5778 | VO_0005162 |
| BBIBP-CorV | Beijing Institute of Biological Products; Sinopharm | July 2020 | 2 | Day 0 + 21 | 5776 | VO_0005166 |
| Chinese Academy of Medical Sciences COVID-19 vaccine (Covidful) | Institute of Medical Biology, Chinese Academy of Medical Sciences | June 9, 2021 | 2 | Day 0 + 28 | 5785 | VO_0005167 |
| CoronaVac (PiCoVacc) | Sinovac | August 28, 2020 | 2 | Day 0 + 14 | 5761 | VO_0005141 |
| COVAXIN (BBV152) | Bharat Biotech | January 3, 2021 | 2 | Day 0 + 14 | 5795 | VO_0004991 |
| COVIran Barakat | Shifa Pharmed Industrial Co | June 13, 2021 | 2 | Day 0 + 14 | 5815 | VO_0005229 |
| CoviVac | Chumakov Centre at the Russian Academy of Sciences | February 20, 2021 | 2 | Day 0 + 14 | 5852 | VO_0005243 |
| KCONVAC | Shenzhen Kangtai Biological Products Co., Ltd., Beijing Minhai Biotechnology Co. | May 14, 2021 | 2 | Day 0 + 28 | 5805 | VO_0005084 |
| QazVac (QazCovid-in) | Research Institute for Biological Safety Problems, National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan | January 13, 2021 | 2 | Day 0 + 21 | 5810 | VO_0005093 |
| WIBP-CorV | Wuhan Institute of Biological Products/ Sinopharm | February 25, 2021 | 2 | Day 0 + 21 | 5775 | VO_0005160 |
| RNA Vaccines | ||||||
| Comirnaty (BNT162b2 , Tozinameran) | BioNTech/Fosun Pharma/Pfizer | December 11, 2020 | 2 | Day 0 + 21 | 5784 | VO_0004987 |
| mRNA-1273 | Moderna | December 18, 2020 | 2 | Day 0 + 28 | 5789 | VO_0005157 |
| Recombinant Vector Vaccines | ||||||
| Ad26.COV2.S (JNJ-78436735) | Janssen Pharmaceutica | February 27, 2021 | 1–2 | Day 0 or Day 0 + 56 | 5782 | VO_0005159 |
| Ad5-nCoV (Convidicea) | CanSino Biologics | June 25, 2020 | 1 | Day 0 | 5768 | VO_0005144 |
| AZD1222 (ChAdOx1 nCoV19, Covishield) | AstraZeneca/University of Oxford | December 30, 2020 | 2 | Day 0 + 28 | 5774 | VO_0005158 |
| Sputnik V (Gam-COVID-Vac) | Gamaleya Research Institute | August 11, 2020 | 2 | Day 0 + 21 | 5777 | VO_0005163 |
| Subunit Vaccines | ||||||
| Abdala | Center for Genetic Engineering and Biotechnology (CIGB) | May 12, 2021 | 3 | Day 0 + 14 + 28 or Day 0 + 28 + 56 | 5803 | VO_0005082 |
| COVAX-19 (SpikoGen) | Vaxine, CinnaGen | October 6, 2021 | 2 | Day 0 + 21 | 5829 | VO_0005193 |
| EpiVacCorona | FBRI State Research Center of Virology and Biotechnology | October 14, 2020 | 2 | Day 0 + 21 | 5794 | VO_0005088 |
| MVC-COV1901 | Medigen, Dynavax | July 19, 2021 | 2 | Day 0 + 28 | 5828 | VO_0005192 |
| NVX-CoV2373 (Covovax) | Novavax | November 1, 2021 | 2 | Day 0 + 21 | 5791 | VO_0005155 |
| Soberana 02 | Instituto Finlay de Vacunas | May 12, 2021 | 2 | Day 0 + 28 | 5814 | VO_0005097 |
| ZF2001 | Anhui Zhifei Longcom Biopharmaceutical; Institute of Microbiology, Chinese Academy of Sciences | March 1, 2021 | 2–3 | Day 0 + 28 or Day 0 + 28 + 56 | 5764 | VO_0005142 |